PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Infectious Diseases Department, Vall d\'Hebron Research Institute (VHIR), Hospital Universitari Vall d\'Hebron, Universitat Autònoma de Barcelona, VHIR Task Force COVID-19, Barcelona, Spain.\', \'Nephrology Research Department, Vall d\'Hebron Research Institute (VHIR), Hospital Universitari Vall d\'Hebron, Universitat Autònoma de Barcelona, VHIR Task Force COVID-19, Barcelona, Spain.\', \'IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, Autonomous University of Barcelona (UAB), Badalona, Spain.\', \'University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain.\', \'AIDS Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.\', \'Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.\', \'Clinic HIV Unit, Hospital Clinic, IDIBAPS, Barcelona, Spain.\', \'Experimental Pathology Department, Institut d\'Investigacions Biomèdiques de Barcelona, Consejo Superior de Investigaciones Científicas (IIBB-CSIC), Institut d\'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.\', \'Centro de Investigaciones Biomédicas en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.\', \'Thoracic Surgery and Lung Transplantation Department, Vall d\'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d\'Hebron, VHIR Task Force COVID-19, Barcelona, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.ppat.1010171
?:doi
?:hasPublicationType
?:journal
  • PLoS pathogens
is ?:pmid of
?:pmid
?:pmid
  • 35025963
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.006
?:rankingScore_hIndex
  • 154
is ?:relation_isRelatedTo_publication of
?:title
  • Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35025963>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35025963>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all